118 related articles for article (PubMed ID: 3266954)
1. A differentiation-inducing factor produced by the osteoblastic cell line MC3T3-E1 stimulates bone resorption by promoting osteoclast formation.
Abe E; Ishimi Y; Takahashi N; Akatsu T; Ozawa H; Yamana H; Yoshiki S; Suda T
J Bone Miner Res; 1988 Dec; 3(6):635-45. PubMed ID: 3266954
[TBL] [Abstract][Full Text] [Related]
2. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
Kaji H; Sugimoto T; Kanatani M; Chihara K
J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111
[TBL] [Abstract][Full Text] [Related]
3. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
4. IL-6 is produced by osteoblasts and induces bone resorption.
Ishimi Y; Miyaura C; Jin CH; Akatsu T; Abe E; Nakamura Y; Yamaguchi A; Yoshiki S; Matsuda T; Hirano T
J Immunol; 1990 Nov; 145(10):3297-303. PubMed ID: 2121824
[TBL] [Abstract][Full Text] [Related]
5. Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation.
Nishiyama K; Sugimoto T; Kaji H; Kanatani M; Kobayashi T; Chihara K
Endocrinology; 1996 Jan; 137(1):35-41. PubMed ID: 8536635
[TBL] [Abstract][Full Text] [Related]
6. Bone-resorbing cytokines enhance release of macrophage colony-stimulating activity by the osteoblastic cell MC3T3-E1.
Felix R; Fleisch H; Elford PR
Calcif Tissue Int; 1989 May; 44(5):356-60. PubMed ID: 2496908
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of colony-stimulating factor (CSF) and differentiation-inducing factor (D-factor) by osteoblastic cells, clone MC3T3-E1.
Shiina-Ishimi Y; Abe E; Tanaka H; Suda T
Biochem Biophys Res Commun; 1986 Jan; 134(1):400-6. PubMed ID: 3484950
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
[TBL] [Abstract][Full Text] [Related]
10. Osteoclast progenitor cells present in significant amounts in mouse calvarial osteoblast isolations and osteoclastogenesis increased by BMP-2.
Granholm S; Henning P; Lindholm C; Lerner UH
Bone; 2013 Jan; 52(1):83-92. PubMed ID: 23017661
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of osteoclastogenesis and osteoclast function by apigenin.
Bandyopadhyay S; Lion JM; Mentaverri R; Ricupero DA; Kamel S; Romero JR; Chattopadhyay N
Biochem Pharmacol; 2006 Jul; 72(2):184-97. PubMed ID: 16750176
[TBL] [Abstract][Full Text] [Related]
13. Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption.
Abe E; Tanaka H; Ishimi Y; Miyaura C; Hayashi T; Nagasawa H; Tomida M; Yamaguchi Y; Hozumi M; Suda T
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5958-62. PubMed ID: 3461468
[TBL] [Abstract][Full Text] [Related]
14. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.
Yamashita T; Asano K; Takahashi N; Akatsu T; Udagawa N; Sasaki T; Martin TJ; Suda T
J Cell Physiol; 1990 Dec; 145(3):587-95. PubMed ID: 1703173
[TBL] [Abstract][Full Text] [Related]
15. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
16. Involvement of PGE synthesis in the effect of intermittent pressure and interleukin-1 beta on bone resorption.
Saito S; Ngan P; Rosol T; Saito M; Shimizu H; Shinjo N; Shanfeld J; Davidovitch Z
J Dent Res; 1991 Jan; 70(1):27-33. PubMed ID: 1991858
[TBL] [Abstract][Full Text] [Related]
17. Continuously applied compressive pressure induces bone resorption by a mechanism involving prostaglandin E2 synthesis.
Imamura K; Ozawa H; Hiraide T; Takahashi N; Shibasaki Y; Fukuhara T; Suda T
J Cell Physiol; 1990 Aug; 144(2):222-8. PubMed ID: 2166056
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
19. The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts.
Chihara K; Sugimoto T
Horm Res; 1997; 48 Suppl 5():45-9. PubMed ID: 9434044
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity.
Kanatani M; Sugimoto T; Nishiyama K; Chihara K
J Bone Miner Res; 2000 May; 15(5):902-10. PubMed ID: 10804020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
